Trial Profile
A Phase 3, Multicenter, Randomized, and Double-blind Study to Evaluate the Safety of Tigecycline versus a Ceftriaxone Regimen in the Treatment of Complicated Intra-abdominal Infections and Community-acquired Pneumonia in Pediatric Subjects Ages 8 to 17 Years Old
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Aminoglycosides; Ceftriaxone; Clarithromycin; Metronidazole
- Indications Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections
- Focus Therapeutic Use
- Sponsors Pfizer; Wyeth; Wyeth Pharmaceuticals
- 31 Jul 2022 This trial has been completed in Belgium, according to European Clinical Trials Database.
- 13 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 06 Jan 2017 This trial has been completed in Hungary (on 2014-12-12), according to European Clinical Trials Database